The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel–Lindau Disease: A Retrospective Study of 32 Patients

Background: Von Hippel-Lindau (VHL) disease is an autosomal-dominant hereditary cancer syndrome. Currently, studies on tyrosine kinase inhibitor (TKI) therapy for VHL disease are scarce. In this study, we retrospectively evaluated the efficacy and safety of four TKIs in patients with VHL disease. Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Kaifang, Hong, Baoan, Zhou, Jingcheng, Gong, Yanqing, Wang, Jiangyi, Liu, Shengjie, Peng, Xiang, Zhou, Bowen, Zhang, Jiufeng, Xie, Haibiao, Zhang, Kenan, Li, Lei, Cai, Desheng, Wang, Zixin, Cai, Lin, Gong, Kan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839035/
https://www.ncbi.nlm.nih.gov/pubmed/31737565
http://dx.doi.org/10.3389/fonc.2019.01122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839035/
https://www.ncbi.nlm.nih.gov/pubmed/31737565
http://dx.doi.org/10.3389/fonc.2019.01122

Ejemplares similares